NewsRoom Articles - Page 205 of 239

FridayDec 08, 2017 11:00 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Partners with Stakeholders to Participate on Global Scale with DehydraTECH™

Amidst increasing awareness regarding potential health benefits of cannabinoids, Lexaria is at the forefront of a booming industry LXRP stakeholders have the opportunity to participate on a global scale to improve the delivery and performance of various products Lexaria’s patented technology provides an enabling layer in cannabinoid research and development, existing products and applications Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™. The technology provides an enabling layer to advances in cannabinoid research and development as…

ThursdayDec 07, 2017 9:00 am

Success of Initial Coin Offerings (ICOs) Shows Increasing Application of Blockchain Technology to Payment Solutions

HempWire Editorial Coverage: Since their genesis in 2008, bitcoin and its underlying blockchain technology have spawned entirely new industries. Blockchain technology appears to be finding application in land registries, in protecting personal identities, in “smart” contracts, and in many other areas. The first employment of blockchain was, of course, bitcoin and cryptocurrencies continue as the main users of the technology. The value of digital currencies is now in the billions, led by bitcoin itself, which skyrocketed to a price above $11,000 as of early December. Moreover, digital coins or tokens have been offered to the public recently in a spate…

WednesdayDec 06, 2017 12:03 pm

Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Providing Clinical Proof of Cannabis Efficiency

Veritas Pharma is unlocking the science underlying medical cannabis Clinically profiling select cannabis strains - pharmacologically identifying strains for specific disease conditions Entering human clinical studies with valuable IP’s in place There is growing support for medicinal cannabis. Repeated peer-reviewed studies have demonstrated positive patient responses in a variety of maladies. However, to date, the response has been largely anecdotal, and, unlike rigorous pharmacology, the precise mechanisms and chemical profiles of cannabinoids remain unknown. Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.…

WednesdayDec 06, 2017 9:00 am

Bitcoin’s Rise Solidifies the Intersection of Cannabis and Cryptocurrency

HempWire Editorial Coverage: As bitcoin’s price continues its meteoric rise, which has seen the cryptocurrency skyrocket in value from just under $1,000 at the start of 2017 to above $10,000 in November, a number of companies have taken steps to benefit from the growth of the burgeoning cryptocurrency industry. One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry, that are blocked from accessing banking services. Among the companies that have oriented their businesses to take advantage of opportunities in…

TuesdayDec 05, 2017 12:08 pm

Skinvisible, Inc. (SKVI) Maximizes Product Development Opportunities with Global Goals

Targeting unmet medical needs with proprietary topical formulations License-based business model translates to worldwide opportunities Patented Invisicare™ technology offers enhanced drug delivery system Global skincare market projected to reach $135 billion by 2021 Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary. The Company’s November 27 announcement that it has entered into a non-binding term sheet regarding a proposed merger with Quoin Pharmaceuticals Ltd., pending customary closing conditions, melds industry veterans committed to…

TuesdayDec 05, 2017 9:27 am

ChineseInvestors.com, Inc. (CIIX) Partners with Global E-commerce Behemoths

Alibaba and Amazon dominate global e-commerce ChineseInvestors.com just successfully launched first hemp-infused skin care products in China Company aims to dominate market When considering e-commerce, Amazon is usually the first name that pops up. However, Alibaba is, by many metrics, both China’s and the world’s largest online e-commerce company. Alibaba commands about 50% market share of business-to-consumer e-commerce in China, while Amazon is the e-commerce elephant in the United States, garnering about 44% of e-commerce sales. To achieve maximum market penetration and global exposure, ChineseInvestors.com, Inc. (OTCQB: CIIX) just successfully launched its OptHemp Product Line on both Amazon and Alibaba.…

MondayDec 04, 2017 11:00 am

Skinvisible, Inc.’s (SKVI) Topical Drug Delivery System Set to Enjoy New Licensing Opportunities

Proven patented polymer drug delivery technology Global topical drug delivery market set for CAGR of 9.2% over next 7 years Strategy to derive revenues from royalties and other licensing fees Skinvisible, Inc. (OTCQB: SKVI) is set for a business renaissance in the coming years. The Nevada-based Company, which develops topical, transdermal and mucosal polymer-based drug delivery systems and formulations that incorporates its patent-pending technology for combining hydrophilic and hydrophobic polymer, is a player in an industry poised to double in size over the next seven years. A new market research report estimates the global topical drug delivery market will grow…

MondayDec 04, 2017 9:21 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Wins in Vegas!

Major interest generated in Lexaria’s technology at MJBizCon Patented technology masks bitter taste of edibles, increases bio-absorption and reduces time to effect Lexaria’s proprietary tech enables lowest manufacturing cost per serving and best consumer experience This year’s three-day Marijuana Business Conference & Expo (MJBizCon) was held in Las Vegas in mid-November, with an attendance of over 18,000 people. Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) had a full team at its exhibit, which attracted a lot of attention. The company noticed increased awareness and knowledge among conference-goers about cannabinoids and their potential health benefits. There was also a noticeable demand…

FridayDec 01, 2017 9:24 am

AppSwarm, Inc. (SWRM) Builds on Mobile Expertise in Crowded Marketplace

App revenue worldwide reaches record levels App downloads rise eight percent between 3Q 2016 and 3Q 2017 AppSwarm building on business app offerings with cannabis industry LOI As the growing number of app downloads and associated revenues continue to hit record levels, AppSwarm, Inc. (OTC: SWRM) is turning its expertise in the mobile gaming industry toward the task of helping smaller online game developers and business utility app makers as they negotiate the crowded app marketplace. AppSwarm uses its proprietary “Swarm” screening process to spot mobile apps with viral potential and help them get to market, where they can connect…

WednesdayNov 29, 2017 9:00 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Offers a Sweet Escape for Cannabis Users without Smoking or Sweeteners

Proprietary lipophilic enhancement technology boosts bioavailability of orally ingested cannabinoids and masks unpleasant taste Only company in the world to obtain a patent for improved oral or ingestible delivery of all cannabinoids, including both non-psychoactive and psychoactive Company generates revenue from out-licensing its technology The cannabis market is exploding globally as well as domestically, and Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids—an advancement from which many cannabis-related companies can profit. Lexaria’s proprietary lipophilic enhancement technology has demonstrated the ability to boost the bioavailability of all orally ingested cannabinoids.…

News and publishing service for hemp related companies

Contact us: 303.498.7722